Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $74.81 is 17.68% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 77.10||$ 153.985|
|Low:||$ 74.38||$ 63.57|
ETFs with ALNY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.57%||First Trust Amex Biotech Index Fund (FBT)||-23.43 (-15.48%)|
|2.27%||Principal Healthcare Innovators Index ETF (BTEC)||-7.08 (-19.42%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
We are a global biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. We are harnessing the RNAi pathway to develop a potential new class of innovative medicines, known as RNAi therapeutics. RNAi therapeutics are comprised of small interfering RNA, or siRNA, and function upstream of today's medicines by potently silencing messenger RNA, or mRNA, that encode for disease-causing proteins, thus preventing them from being made. This is a revolutionary approach with the potential to transform the care of patients with genetic and other diseases. Our research and development strategy is to target genetically validated liver-expressed genes that have been implicated in the cause or pathway of human disease. ... More ...
Nasdaq Official Price
Dec. 18, 2018
Dec. 17, 2018